Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 16 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Esophageal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Adenocarcinoma 3 Colorectal Neoplasms 2 Biliary Tract Neoplasms 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Locally Advanced Gastric Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Clinical Stage I Gastric Cancer AJCC v8 1 Childhood Solid Tumor 1 Breast Neoplasm Malignant Female 1 Brain Neoplasms 1 Advanced Solid Tumour 1 Advanced Rectal Cancer 1 Adjuvant Drug Therapy 1

Interventions

Radiotherapy 5 Oxaliplatin 5 Nivolumab 5 Fluorouracil 5 Cetuximab 5 Leucovorin 4 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 sintilimab 2 pembrolizumab 2 fludarabine 2 encorafenib 2 aldesleukin 2 Tomography, X-Ray Computed 2 Specimen Handling 2 Pemetrexed 2 Magnetic Resonance Imaging 2 Irinotecan 2 Gemcitabine 2 Folfox protocol 2 Electrocardiography 2 Drug Therapy 2 Dexamethasone 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Biopsy 2 ulixertinib 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Capecitabine × 30 days × Clear all

NCT07622017 2026-06-02

K-BOOST

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡